Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07178808 · ClinicalTrials.gov registry record · Phase 2
Phase II Evaluation OF Cytoreduction Surgery AND Hyperthermic Intraperitoneal Chemotherapy (crs/hipec) IN Gastric Cancer
A Phase 2 study of Gastric Adenocarcinoma, sponsored by Banner Health.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07178808 is a Phase 2 study of Gastric Adenocarcinoma that is actively recruiting participants, run by Banner Health. The registered enrollment target is 30 participants, below the 245-participant average among 47 other Gastric Adenocarcinoma trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07178808, a Phase 2 study of Gastric Adenocarcinoma, is actively recruiting participants, sponsored by Banner Health.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase II treatment study analyzing the role of preoperative chemotherapy, preoperative laparoscopic HIPEC, and gastrectomy with CRS/HIPEC in gastric adenocarcinoma patients with cytology-positive only carcinomatosis, radiologically-occult carcinomatosis, or radiology apparent peritoneal-surface only metastatic disease.
Conditions Studied
Interventions
- PROCEDURE Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Study Locations (1)
Arizona
- Banner MD Anderson Cancer Center - Gilbert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-04-16 |
| Est. Completion | 2031-02-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07178808
The ClinicalTrials.gov registry entry for NCT07178808 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 47 other Gastric Adenocarcinoma trials with a reported enrollment target (88% lower). The listed sponsor is Banner Health, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastric Adenocarcinoma appearing as the primary indexed condition, and to 1 intervention - of which Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is the first listed.
NCT07178808 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT07178808 about?
NCT07178808 is a clinical study titled "Phase II Evaluation OF Cytoreduction Surgery AND Hyperthermic Intraperitoneal Chemotherapy (crs/hipec) IN Gastric Cancer". This is a Phase II treatment study analyzing the role of preoperative chemotherapy, preoperative laparoscopic HIPEC, and gastrectomy with CRS/HIPEC in gastric adenocarcinoma patients with cytology-positive only carcinomatosis, radiologically-occult carcinomatosis, or radiology apparent peritoneal-su...
What is the current status of trial NCT07178808?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2021-04-16. Estimated completion is 2031-02-22.
What conditions does trial NCT07178808 study?
This clinical trial studies the following conditions: Gastric Adenocarcinoma.
What interventions are being tested in trial NCT07178808?
The interventions under investigation include: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT07178808?
This trial is sponsored by Banner Health, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07178808 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastric Adenocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RECRUITING · Phase 2
-
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study
RECRUITING · Phase 2
-
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
RECRUITING · Phase 2
-
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
RECRUITING · Phase 2
-
A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
RECRUITING · Phase 2
-
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.